Clinical Trial Update: Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 study evaluating the hydromorphone–naloxone fixed-dose ratio for pain management; constipation is listed as a condition in the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Hydromorphone-Naloxone (hydromorphone-naloxone fixed-dose combination)

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Constipation | Phase 2, Phase 3 | Status: COMPLETED